Month Formulation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Month Formulation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Month Formulation Today - Breaking & Trending Today

Alkermes Presents Clinical and Real-World Data at 36th Annual Psych Congress

Published: September 11, 2023

/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced the presentation of multiple posters highlighting real-world and clinical data at the 36th Annual...

Source: prnewswire.com

Related Topics:

United StatesMarisa BorgasanoSandy CoombsAripiprazole LauroxilCraig HopkinsonResearch Development At AlkermesAlkermes Pharma IrelandUs National HealthWellness Survey DataPsych CongressMental HealthAlkermes IncPoster Presentations Highlight CompanyBroad Research CommitmentSerious Mental IllnessAnnual Psych CongressChief Medical OfficerExecutive Vice PresidentPatient PerspectiveIn Depth QualitativeMonth FormulationAcute SchizophreniaPost Hoc AnalysisKey CharacteristicsAtypical Long Acting Injectable

Janssen to Showcase New Insights and Commitment to Accelerating Hope and Healing for Serious Mental Illness at Psych Congress 2023

Published: September 5, 2023

/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson will showcase data from its neuropsychiatry portfolio at Psych Congress 2023. The...

Source: prnewswire.com

Related Topics:

United StatesReina BenabouBill MartinJanssen Pharmaceutical CompaniesWorld Health OrganizationPsych CongressNational Council For MentalNational Institute Of Mental HealthJanssen Pharmaceutical Companies Of JohnsonExchange CommissionJanssen Research DevelopmentUs Census BureauNational Pregnancy Registry For Atypical AntipsychoticsJanssen Biotech IncCompanies Of JohnsonNone Of Janssen ResearchJanssen Pharmaceuticals IncAmerican Psychiatric AssociationNational Alliance On Mental IllnessJanssen ResearchJanssen Scientific AffairsNational Pregnancy Registry For AntidepressantsVice PresidentMedical AffairsRisk Evaluation